Compared to the results of others looking at different AML subtypes in a much larger cohort of patients [25], we also found that AML patients harboring EZH2 mutations were mostly older individuals and had a median of 4 mutations in genes associated with myeloid malignancies. This evidence concerns the gene EZH2 and acute myeloid leukemia.